Credit Suisse Group Analysts Give Swiss Re (SREN) a CHF 99 Price Target

Credit Suisse Group set a CHF 99 price objective on Swiss Re (VTX:SREN) in a research note issued to investors on Wednesday morning. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts have also recently issued reports on the stock. JPMorgan Chase & Co. set a CHF 120 target price on shares of Swiss Re and gave the company a buy rating in a report on Friday, August 3rd. UBS Group reissued a sell rating on shares of Swiss Re in a report on Wednesday, October 10th. Deutsche Bank set a CHF 101 target price on shares of Swiss Re and gave the company a neutral rating in a report on Monday, July 23rd. Barclays set a CHF 101.70 target price on shares of Swiss Re and gave the company a buy rating in a report on Friday, September 7th. Finally, Societe Generale set a CHF 106 target price on shares of Swiss Re and gave the company a buy rating in a report on Friday, August 3rd. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and ten have given a buy rating to the company’s stock. The company has an average rating of Hold and an average price target of CHF 99.17.

Shares of SREN stock opened at CHF 97.12 on Wednesday. Swiss Re has a 1 year low of CHF 81.65 and a 1 year high of CHF 98.80.



Swiss Re Company Profile

Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.

Featured Article: How Buying a Call Option Works

Analyst Recommendations for Swiss Re (VTX:SREN)

Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply